103 related articles for article (PubMed ID: 3141346)
1. Influence of subinhibitory concentrations of ceftriaxone on opsonization and killing of Pseudomonas aeruginosa by human neutrophils.
Labro MT; Babin-Chevaye C; Hakim J
J Antimicrob Chemother; 1988 Sep; 22(3):341-52. PubMed ID: 3141346
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cefodizime with various cephalosporins for their indirect effect on the human neutrophil oxidative burst in vitro.
Labro MT; el Benna J
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():49-57. PubMed ID: 2127416
[TBL] [Abstract][Full Text] [Related]
3. Effect of ceftriaxone on Pseudomonas aeruginosa and Staphylococcus aureus in broth, serum, and in combination with human polymorphonuclear leukocytes.
Bassler M; Blaschke H; Just M; Daschner FD
Chemotherapy; 1982; 28(5):390-6. PubMed ID: 6291868
[TBL] [Abstract][Full Text] [Related]
4. Interaction of ceftriaxone with human polymorphonuclear neutrophil function.
Labro MT; Babin-Chevaye C; Pochet I; Hakim J
J Antimicrob Chemother; 1987 Dec; 20(6):849-55. PubMed ID: 2831183
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal effect of polymorphonuclear leukocytes on Pseudomonas aeruginosa pre-incubated in ofloxacin.
Nielsen B; Nielsen H
Acta Pathol Microbiol Immunol Scand B; 1987 Aug; 95(4):227-32. PubMed ID: 3118637
[TBL] [Abstract][Full Text] [Related]
6. Effect of ceftriaxone-induced alterations of bacteria on neutrophil bactericidal function.
Labro MT; Pochet I; Babin-Chevaye C; Hakim J
J Antimicrob Chemother; 1987 Dec; 20(6):857-69. PubMed ID: 3326873
[TBL] [Abstract][Full Text] [Related]
7. Bacteriological and ultrastructural studies on the effect of subinhibitory beta-lactam concentrations on intraphagocytic killing of Pseudomonas aeruginosa by human polymorphonuclear leukocytes.
Stübner G; Dalhoff A; Voigt WH
Arzneimittelforschung; 1986 Jun; 36(6):899-904. PubMed ID: 3091042
[TBL] [Abstract][Full Text] [Related]
8. Influence of subinhibitory concentrations of antibiotics on opsonization and phagocytosis of Pseudomonas aeruginosa by human polymorphonuclear leukocytes.
Milatovic D
Eur J Clin Microbiol; 1984 Aug; 3(4):288-93. PubMed ID: 6436020
[TBL] [Abstract][Full Text] [Related]
9. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
[TBL] [Abstract][Full Text] [Related]
10. Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophils.
Thomsen K; Christophersen L; Jensen PØ; Bjarnsholt T; Moser C; Høiby N
Hum Vaccin Immunother; 2016 Jul; 12(7):1690-9. PubMed ID: 26901841
[TBL] [Abstract][Full Text] [Related]
11. Some bacterial parameters influencing the neutrophil oxidative burst response to Pseudomonas aeruginosa biofilms.
Jensen ET; Kharazmi A; Høiby N; Costerton JW
APMIS; 1992 Aug; 100(8):727-33. PubMed ID: 1325804
[TBL] [Abstract][Full Text] [Related]
12. Enhanced killing of Pseudomonas aeruginosa by human polymorphonuclear leukocytes in presence of subinhibitory concentrations of carbenicillin and ticarcillin.
Petit JC; Daguet GL
Biomedicine; 1981 Feb; 34(1):29-33. PubMed ID: 6784781
[TBL] [Abstract][Full Text] [Related]
13. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment of Pseudomonas aeruginosa with a sub-MIC of imipenem enhances bactericidal activity of neutrophils.
Sasahara T; Satoh Y; Sekiguchi T; Suzuki K; Irinoda K; Takayama Y; Sakamoto A; Kitasato H; Okamoto R; Inoue M
J Infect Chemother; 2003 Dec; 9(4):297-303. PubMed ID: 14691649
[TBL] [Abstract][Full Text] [Related]
15. Toll-Like Receptor 4 Agonistic Antibody Promotes Host Defense against Chronic Pseudomonas aeruginosa Lung Infection in Mice.
Nakamura S; Iwanaga N; Seki M; Fukudome K; Oshima K; Miyazaki T; Izumikawa K; Yanagihara K; Miyazaki Y; Mukae H; Kohno S
Infect Immun; 2016 Jul; 84(7):1986-1993. PubMed ID: 27091927
[TBL] [Abstract][Full Text] [Related]
16. The influence of subminimal inhibitory concentrations of netilmicin and ceftriaxone on the interaction of Escherichia coli with host defences.
Raponi G; Vreede RW; Rozenberg-Arska M; Hoepelman IM; Keller N; Verhoef J
J Antimicrob Chemother; 1989 Apr; 23(4):565-76. PubMed ID: 2663813
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of subinhibitory concentrations of ciprofloxacin against Pseudomonas aeruginosa as determined by the killing curve method and the postantibiotic effect.
Zhanel GG; Crampton J; Kim S; Nicolle LE; Davidson RJ; Hoban DJ
Chemotherapy; 1992; 38(6):388-94. PubMed ID: 1288962
[TBL] [Abstract][Full Text] [Related]
18. Preincubation of Haemophilus influenzae with subinhibitory concentrations of macrolides: influence on human neutrophil chemiluminescence.
Bonnet M; Van der Auwera P
Antimicrob Agents Chemother; 1993 May; 37(5):1015-24. PubMed ID: 8390808
[TBL] [Abstract][Full Text] [Related]
19. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay.
LeBlanc CM; Bortolussi R; Issekutz AC; Gillespie T
Clin Invest Med; 1982; 5(2-3):125-8. PubMed ID: 6811181
[TBL] [Abstract][Full Text] [Related]
20. Enoxacin-induced alteration of susceptibility of pneumococci and Pseudomonas to phagocytosis by human polymorphonuclear leukocytes.
Pruul H; Hill N; McDonald PJ
J Antimicrob Chemother; 1984 Sep; 14 Suppl C():19-31. PubMed ID: 6438047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
